Cargando…
Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study
PURPOSE: We evaluated the feasibility of patient symptom self-reporting using a web-based interface (WBI), with automated message alerts for severe and/or worsening symptoms, in patients undergoing definitive chemoradiation therapy (CRT). METHODS AND MATERIALS: Patients receiving definitive CRT for...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238265/ https://www.ncbi.nlm.nih.gov/pubmed/37273926 http://dx.doi.org/10.1016/j.adro.2022.101073 |
_version_ | 1785053255897710592 |
---|---|
author | Ma, Ting Martin Yang, Tiffany Philipson, Rebecca Kishan, Amar U. Lee, Percy Raldow, Ann C. |
author_facet | Ma, Ting Martin Yang, Tiffany Philipson, Rebecca Kishan, Amar U. Lee, Percy Raldow, Ann C. |
author_sort | Ma, Ting Martin |
collection | PubMed |
description | PURPOSE: We evaluated the feasibility of patient symptom self-reporting using a web-based interface (WBI), with automated message alerts for severe and/or worsening symptoms, in patients undergoing definitive chemoradiation therapy (CRT). METHODS AND MATERIALS: Patients receiving definitive CRT for gastrointestinal, lung, and head and neck cancers with access to a computer and/or mobile device were eligible. Symptom self-reporting was conducted via a WBI through surveys adapted from the patient-reported outcomes version of the Common Terminology Criteria for Adverse Events: 2 per week during CRT and 1 per week for 3 months after CRT. Nurses were alerted whenever a patient's symptom worsened by ≥2 points or reached a score of ≥3. Patient-Reported Outcomes Measurement Information System (PROMIS) surveys were conducted at baseline, end of CRT, and 3 months after CRT. Patients also completed exit surveys 3 months after CRT. RESULTS: Nineteen patients were enrolled with a median of 30 fractions (range, 28-33). The median survey completion rate was 26% (range, 0%-100%) during CRT and 33% (range, 0%-100%) during the first 3 months after CRT. Five (26%) had acute hospital encounters during CRT or within 3 months of CRT completion. Two patients (11%) experienced CRT treatment interruptions. During CRT, 70 of 81 surveys (86%) were flagged and 61 of 70 (87%) were acted upon by a nurse or physician within 4 days; during the first 3 months after CRT, 47 of 85 (55%) were flagged and 28 of 47 (60%) were acted upon within 7 days. Ninety-two percent of patients found it always easy to access the survey while 58% found the surveys too long or too frequent. None of the PROMIS domains had statistically significant changes during any time points. CONCLUSIONS: Symptom self-reporting via a WBI is feasible during definitive chemoradiation with high patient satisfaction. Survey fatigue is common and may be mitigated by improving the WBI to make it more patient-centered and allowing patients to choose which symptoms to report. |
format | Online Article Text |
id | pubmed-10238265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-102382652023-06-04 Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study Ma, Ting Martin Yang, Tiffany Philipson, Rebecca Kishan, Amar U. Lee, Percy Raldow, Ann C. Adv Radiat Oncol Scientific Article PURPOSE: We evaluated the feasibility of patient symptom self-reporting using a web-based interface (WBI), with automated message alerts for severe and/or worsening symptoms, in patients undergoing definitive chemoradiation therapy (CRT). METHODS AND MATERIALS: Patients receiving definitive CRT for gastrointestinal, lung, and head and neck cancers with access to a computer and/or mobile device were eligible. Symptom self-reporting was conducted via a WBI through surveys adapted from the patient-reported outcomes version of the Common Terminology Criteria for Adverse Events: 2 per week during CRT and 1 per week for 3 months after CRT. Nurses were alerted whenever a patient's symptom worsened by ≥2 points or reached a score of ≥3. Patient-Reported Outcomes Measurement Information System (PROMIS) surveys were conducted at baseline, end of CRT, and 3 months after CRT. Patients also completed exit surveys 3 months after CRT. RESULTS: Nineteen patients were enrolled with a median of 30 fractions (range, 28-33). The median survey completion rate was 26% (range, 0%-100%) during CRT and 33% (range, 0%-100%) during the first 3 months after CRT. Five (26%) had acute hospital encounters during CRT or within 3 months of CRT completion. Two patients (11%) experienced CRT treatment interruptions. During CRT, 70 of 81 surveys (86%) were flagged and 61 of 70 (87%) were acted upon by a nurse or physician within 4 days; during the first 3 months after CRT, 47 of 85 (55%) were flagged and 28 of 47 (60%) were acted upon within 7 days. Ninety-two percent of patients found it always easy to access the survey while 58% found the surveys too long or too frequent. None of the PROMIS domains had statistically significant changes during any time points. CONCLUSIONS: Symptom self-reporting via a WBI is feasible during definitive chemoradiation with high patient satisfaction. Survey fatigue is common and may be mitigated by improving the WBI to make it more patient-centered and allowing patients to choose which symptoms to report. Elsevier 2022-10-25 /pmc/articles/PMC10238265/ /pubmed/37273926 http://dx.doi.org/10.1016/j.adro.2022.101073 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Ma, Ting Martin Yang, Tiffany Philipson, Rebecca Kishan, Amar U. Lee, Percy Raldow, Ann C. Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study |
title | Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study |
title_full | Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study |
title_fullStr | Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study |
title_full_unstemmed | Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study |
title_short | Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study |
title_sort | web-based symptom monitoring with patient-reported outcomes during definitive radiation therapy with chemotherapy (sympathy): a prospective single-center phase 1 study |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238265/ https://www.ncbi.nlm.nih.gov/pubmed/37273926 http://dx.doi.org/10.1016/j.adro.2022.101073 |
work_keys_str_mv | AT matingmartin webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study AT yangtiffany webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study AT philipsonrebecca webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study AT kishanamaru webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study AT leepercy webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study AT raldowannc webbasedsymptommonitoringwithpatientreportedoutcomesduringdefinitiveradiationtherapywithchemotherapysympathyaprospectivesinglecenterphase1study |